Deutsche Bank Starts Intercept Pharmaceuticals (ICPT) at Buy
Tweet Send to a Friend
Deutsche Bank initiated coverage on Intercept Pharmaceuticals (NASDAQ: ICPT) with a Buy rating and a price target of $395. Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE